Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/29/1999CN1239950A New derivates from piperidine-keto acid, their preparation and use
12/29/1999CN1239949A Novel heterocyclically substituted benzamides and their use in fighting diseases
12/29/1999CN1239946A Formulations and polymorphic forms of desferrioxamine and the preparation thereof
12/29/1999CN1239944A New pentaerythritol derivatives, their production, and use and intermdiates for their synthesis
12/29/1999CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs.
12/29/1999CN1239895A Radiopharmaceuticals for imaging infection and inflammation
12/29/1999CN1239894A Inositol polyphosphate derivatives and method of using same
12/29/1999CN1239893A Hormonal composition consisting of oestrogen compound and progestational compound
12/29/1999CN1239892A Use of equilenin as antioxidant
12/29/1999CN1239891A Use of 17 '-dihydroequilenin as an antioxidant
12/29/1999CN1239890A 17 'alpha'-dihydroequilenin for use as medical antioxidant
12/29/1999CN1239888A Method for inhibiting stress-activated protein kinases
12/29/1999CN1239887A Pharmaceutical compositions containing N-sulphonyl indolin derivatives
12/29/1999CN1239886A Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent
12/29/1999CN1239885A Felbinac-containing patch
12/29/1999CN1239718A 11-acetyl-12,13-dioxa bicyclo [8.2.1] tridecenone -derivative, its preparation and medicine containing the compound
12/29/1999CN1239657A Antisticking particle and powder containing sodium hyaluronate and their preparation process
12/29/1999CN1239656A Compound transdermal nicotine-clonidine paster for giving up smoking
12/29/1999CN1047780C Extraction, separation and purification of 'Jingu' mushroom holoside Ge and its inhibition effect on reverse-transcriptase of Aids virus
12/29/1999CN1047778C Pyrimido [5,4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them
12/29/1999CN1047776C Pharmacologically active pyridine derivatives and process for the preparation thereof
12/29/1999CN1047775C N-piperidino 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl pyrazole-3-formyl amide, its preparation and drug composition
12/29/1999CN1047732C Transcutaneous huperzing sticker
12/29/1999CA2618288A1 Antisense oligonucleotide constructs based on .beta.-arabinofuranose and its analogues
12/29/1999CA2346954A1 Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
12/29/1999CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999CA2336201A1 Compositions and methods for inhibiting bone resorption
12/29/1999CA2336192A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999CA2336160A1 Use of compounds for treating hiv
12/29/1999CA2336135A1 Mumbaistatin, a process for its production and its use as a pharmaceutical
12/29/1999CA2336095A1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
12/29/1999CA2336003A1 Amidino and guanidino azetidinone tryptase inhibitors
12/29/1999CA2335989A1 Stable no-delivering compounds
12/29/1999CA2335956A1 Compounds obtained from salvia species having antiviral activity
12/29/1999CA2335876A1 Protease inhibitors
12/29/1999CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999CA2335809A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999CA2335799A1 Novel compounds derived from .alpha.-d-xylose, preparation method and therapeutic use
12/29/1999CA2335781A1 Oxidation inhibitors for prostane derivatives
12/29/1999CA2335768A1 Cephem compounds
12/29/1999CA2335758A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999CA2335736A1 A device and method for the treatment of erectile dysfunction
12/29/1999CA2335711A1 4,5,6 and 7-indole and indoline derivatives, their preparation and use
12/29/1999CA2335641A1 The use of valproic acid analog for the treatment and prevention of migraine and affective illness
12/29/1999CA2335598A1 2-fluoro-2-alkyl alkanoamides with anticonvulsant activity
12/29/1999CA2335571A1 (heterocyclic) methyl substituted carbapenem antibacterials
12/29/1999CA2335559A1 Arylsulfonanilide phosphates
12/29/1999CA2335545A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
12/29/1999CA2335538A1 (heterocyclic)methyl substituted carbapenem antibacterials
12/29/1999CA2335513A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999CA2335510A1 Naphtho[1,8-de]thiasin-2-yl methyl carbapenem antibacterials
12/29/1999CA2335507A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/29/1999CA2335497A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/29/1999CA2335471A1 Compositions and methods for inhibiting bone resorption
12/29/1999CA2335373A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
12/29/1999CA2335366A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999CA2335356A1 Nitrate salts of antihypertensive medicines
12/29/1999CA2335329A1 Meiosis regulating compounds
12/29/1999CA2335288A1 Propenyl cephalosporin derivatives
12/29/1999CA2335193A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones
12/29/1999CA2335190A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases
12/29/1999CA2334973A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
12/29/1999CA2334645A1 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
12/29/1999CA2334550A1 Method and compositions for the treatment or amelioration of female sexual dysfunction
12/29/1999CA2334322A1 Syntheses of a variety of lamellarin compounds and analogues
12/29/1999CA2334307A1 Derivatized polymers of .alpha.-olefin-maleic anhydride alkyl half-ester or full acid
12/29/1999CA2333586A1 Matrix-type transdermal patch for steroid hormones
12/29/1999CA2331923A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
12/29/1999CA2331919A1 Structured antisense nucleic acid molecules
12/29/1999CA2325389A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999CA2325388A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999CA2324475A1 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds
12/29/1999CA2324474A1 Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
12/29/1999CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors
12/29/1999CA2301107A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action
12/29/1999CA2294075A1 Herbal extract composition and method with immune-boosting capability
12/29/1999CA2241853A1 Valproic acid conjugates
12/28/1999US6008385 Centrifugal partition chromatography to purify taxoides such a taxotere using atleast two solvents selected from esters, ethers, aliphatic hydrocarbons and ketones
12/28/1999US6008383 Method of preparing delta-9-tetrahydrocannabinol esters
12/28/1999US6008367 Intermediate for synthesis of anticoagulant agents
12/28/1999US6008365 Adrenoreceptor agonists and dopamine da2-receptor agonists, useful in the treatment of obstructive airway diseases
12/28/1999US6008357 1 -azabicyclo(2.2.2)octan-3-amine, (2-diphenylmethyl)-n-((2-methoxy-5-(1-methylethyl)phenyl)methy l) is reacted with 1r-(-)-10-camphorsulfonic acid to obtain camphorsulfonic acid salt
12/28/1999US6008356 Pharmaceutically available protoberberine salts derivatives, and protoberberine salts derivatives, and protoberberine derivatives and salts thereof
12/28/1999US6008355 Oxidizing codeine to form codeinone, converting codeinone to oxycodone in a two step one pot reaction: reacting codeinone with hydrogen peroxide in water in presence of an acid to form 14-hydroxycodeinone then hydrogenating the intermediate
12/28/1999US6008354 Protecting hydroxy group of morphine in 3 and 6 position, demethylating n-methyl on 17 position and hydrolizing the acyl group, forming 17-benzyl-3(o)protected group, oxidizing to form intermediate, hydrogenation of intermediate
12/28/1999US6008351 Peptide aldehyde compounds having uracil or pyrimidin-4-one groups as part of the peptide backbone; potent inhibitors of thrombin
12/28/1999US6008347 N-substituted 2-azetidinones
12/28/1999US6008336 Compacted nucleic acids and their delivery to cells
12/28/1999US6008333 Preparation of glucosaminyl muramic acid derivatives
12/28/1999US6008260 Cancer chemopreventative composition and method
12/28/1999US6008258 d-methadone, a nonopioid analegesic
12/28/1999US6008256 Comprises (a) lidocaine, (b) epinephrine in specific amount, and (c) one or more amino acids; excellent storage stability
12/28/1999US6008255 Treating endotoxic shock by administering compounds of given formula which are aromatics substituted with multiple guanylhydrazone moieties, more properly termed amidinohydrazones (h2n-c(=nh)-nh-n=)
12/28/1999US6008254 Method of treating skin disorders with high-strength tretinoin
12/28/1999US6008253 Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal
12/28/1999US6008252 Administering a therapeutically effective amount of calcium pyruvate or potassium pyruvate, and exercising the subject anaerobically 20 minutes per day
12/28/1999US6008248 An isotonic mixtures comprising medium-chain triglycerides, vegetable oils and fish oil for treating inflammatory reaction, or an increased risk of vascular thrombosis, or severe cardiac arrythmia
12/28/1999US6008247 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents
12/28/1999US6008245 Treatment of prophylaxis and cardiovascular disorders, in particular arrhythmias, for the treatment of ulcers of the gastrointestinal disorders, diarrheal diseases
1 ... 6388 6389 6390 6391 6392 6393 6394 6395 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 ... 7860